Log In
BCIQ
Print this Print this
 

Nicotinic acetylcholine receptor alpha(3)beta(4)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Nicotinic acetylcholine receptor alpha(3)beta(4)

BCIQ
Print ChartPrint this
1 0 0 1
Phases of DevelopmentPreclinicalPhase I
Infectious

0

1

Neurology

1

0




 Products Targeting Nicotinic acetylcholine receptor alpha(3)beta(4)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$1,280.0M

$240.0M

$1,040.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today